One Year Later: Medical Abortion After FDA Approval
On September 28, 2000, the Food and Drug Administration (FDA) approved mifepristone (RU486), the first dedicated medical abortion pill regimen. Many advocates on both sides of the abortion debate predicted that arrival of this new option would transform the abortion landscape – for women, for doctors, and for politicians. So, a year later, where are we?
also of interest
- Sexual Health of Adolescents and Young Adults in the United States
- Data Note: Differences In Public Opinion On The ACA's Contraceptive Coverage Requirement, By Gender, Religion, And Political Party
- Potential Supreme Court Decision: Who Will Bear the Coverage “Burdens?”
- Women and Health Care in the Early Years of the ACA: Key Findings from the 2013 Kaiser Women's Health Survey